ABCL logoABCL
AbCellera Biologics Inc

7,893
Loading...
Loading...
News
all
press releases
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +29.41% and +146.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
More News
News Placeholder
Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
Myriad (MYGN) delivered earnings and revenue surprises of +600.00% and +5.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ABCELLERA BIOLG (ABCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
ABCELLERA BIOLG (ABCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·2mo ago
News Placeholder
ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why
Zacks·3mo ago
News Placeholder
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
chainwire·4mo ago
News Placeholder
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The expansion...
Business Wire·8mo ago
News Placeholder
AbCellera to Present at Upcoming Investor Conferences in December and January
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences: Piper Sandler 36th Annual Healthcare Conference in New York, NY on...
Business Wire·10mo ago
News Placeholder
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting at the George...
Business Wire·10mo ago
News Placeholder
AbCellera Reports Q3 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated...
Business Wire·10mo ago

Latest ABCL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.